Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Albemarle's Current Accrued Expense for the quarter that ended in Jun. 2026 was MXN8,856 Mil.
Albemarle's quarterly Current Accrued Expense
increased
from Dec. 2025 (MXN5,195 Mil) to Mar. 2026 (MXN8,167 Mil) and
increased
from Mar. 2026 (MXN8,167 Mil) to Jun. 2026 (MXN8,856 Mil).
Albemarle's annual Current Accrued Expense
increased
from Dec. 2023 (MXN6,390 Mil) to Dec. 2024 (MXN6,439 Mil) but then
declined
from Dec. 2024 (MXN6,439 Mil) to Dec. 2025 (MXN5,195 Mil).
The historical data trend for Albemarle's Current Accrued Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.
What does a Current Accrued Expense of MXN8,856 Mil mean?
Albemarle (MEX:ALB) has a Current Accrued Expense of MXN8,856 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Albemarle and its competitors.
Is Albemarle's Current Accrued Expense too high?
Albemarle's current Current Accrued Expense is MXN8,856 Mil. Overall, Albemarle has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Albemarle's Current Accrued Expense compare to RPM and SOLS?
Albemarle's Current Accrued Expense of MXN8,856 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Chemicals company?
A good Current Accrued Expense depends on the Chemicals industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Albemarle and its competitors. Albemarle's current Current Accrued Expense is MXN8,856 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albemarle stock overvalued right now?
Based on GuruFocus' analysis, Albemarle (MEX:ALB) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,372.55, compared to a current price of MXN2,238.00 — trading 63.1% above its estimated fair value. The current Current Accrued Expense is MXN8,856 Mil. Albemarle's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Albemarle (MEX:ALB), the current Current Accrued Expense is MXN8,856 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Albemarle (MEX:ALB) Overvalued in 2026?
Based on GuruFocus' analysis, Albemarle stock appears to be overvalued.
The current stock price of MXN2,238.00 is trading 63.1% above its estimated GF Value™ of MXN1,372.55.
GuruFocus considers Albemarle to be Significantly Overvalued.
Key valuation signals for MEX:ALB:
Current Accrued Expense: MXN8,856 Mil
GF Value™: MXN1,372.55 vs. price of MXN2,238.00 (63.1% above fair value)
No single metric tells the full story. See the MEX:ALB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
67GF Score
Get the complete analysis for MEX:ALB
Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ALB has been successfully added to your 
